ELOXX PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
ELOXX PHARMACEUTICALS, INC. (ELOX) had Shares Outstanding (Cover Page) of 4.04 million shares as of 2026-08-07, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-07: Entity Common Stock, Shares Outstanding 4.04M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 7.57M shares.
- 2026-03-12: Entity Common Stock, Shares Outstanding 5.07M shares.
- 2023-11-08: Entity Common Stock, Shares Outstanding 3.14M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 4.04M shares 10-Q · filed 2026-08-11 |
| 2026-05-01 | 7.57M shares 10-Q · filed 2026-05-05 |
| 2026-03-12 | 5.07M shares 10-K · filed 2026-03-17 |
| 2023-11-08 | 3.14M shares 10-Q · filed 2023-11-13 |
| 2023-08-09 | 2.75M shares 10-Q · filed 2023-08-11 |
| 2023-05-10 | 2.17M shares 10-Q · filed 2023-05-12 |
| 2023-03-27 | 2.17M shares 10-K · filed 2023-03-31 |
| 2022-11-08 | 86.66M shares 10-Q · filed 2022-11-10 |
| 2022-08-10 | 86.66M shares 10-Q · filed 2022-08-12 |
| 2022-05-03 | 86.65M shares 10-Q · filed 2022-05-06 |
| 2022-03-25 | 86.65M shares 10-K · filed 2022-03-30 |
| 2021-11-03 | 86.25M shares 10-Q · filed 2021-11-08 |
| 2021-08-09 | 86.20M shares 10-Q · filed 2021-08-16 |
| 2021-05-03 | 47.86M shares 10-Q · filed 2021-05-07 |
| 2021-03-08 | 40.21M shares 10-K · filed 2021-03-12 |
| 2020-11-02 | 40.15M shares 10-Q · filed 2020-11-06 |
| 2020-08-03 | 40.14M shares 10-Q · filed 2020-08-07 |
| 2020-05-04 | 40.13M shares 10-Q · filed 2020-05-08 |
| 2020-03-01 | 40.12M shares 10-K · filed 2020-03-06 |
| 2019-11-01 | 40.00M shares 10-Q · filed 2019-11-06 |
| 2019-08-01 | 39.94M shares 10-Q · filed 2019-08-07 |
| 2019-05-03 | 36.03M shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 35.86M shares 10-K · filed 2019-03-14 |
| 2018-11-01 | 35.12M shares 10-Q · filed 2018-11-08 |
| 2018-08-03 | 34.86M shares 10-Q · filed 2018-08-10 |
| 2018-05-07 | 33.43M shares 10-Q · filed 2018-05-10 |
| 2017-12-31 | 27.53M shares 10-K · filed 2018-03-16 |
| 2017-10-31 | 51.41M shares 10-Q · filed 2017-11-14 |
| 2017-09-25 | 51.41M shares 10-K · filed 2017-10-13 |
| 2017-04-28 | 26.92M shares 10-Q · filed 2017-05-22 |
| 2017-02-01 | 20.74M shares 10-Q · filed 2017-02-10 |
| 2016-11-01 | 20.64M shares 10-Q · filed 2016-11-14 |
| 2016-09-30 | 20.50M shares 10-K · filed 2016-10-13 |
| 2016-05-09 | 20.42M shares 10-Q · filed 2016-05-12 |
| 2016-02-05 | 20.42M shares 10-Q · filed 2016-02-16 |
| 2015-10-31 | 20.42M shares 10-Q · filed 2015-11-16 |
| 2015-09-15 | 20.39M shares 10-K · filed 2015-10-09 |
| 2015-05-11 | 16.39M shares 10-Q · filed 2015-05-14 |
| 2015-01-31 | 13.87M shares 10-Q · filed 2015-02-17 |
| 2014-10-31 | 13.87M shares 10-Q · filed 2014-11-14 |
| 2014-09-15 | 13.85M shares 10-K · filed 2014-09-29 |
| 2014-04-30 | 6.91M shares 10-Q · filed 2014-05-09 |
| 2014-01-31 | 5.04M shares 10-Q · filed 2014-02-14 |
| 2013-10-31 | 3.16M shares 10-Q · filed 2013-11-14 |
| 2013-08-31 | 231.90M shares 10-K · filed 2013-09-11 |
| 2013-05-10 | 194.71M shares 10-Q · filed 2013-05-15 |
| 2013-01-31 | 146.98M shares 10-Q · filed 2013-02-14 |
| 2012-10-31 | 116.98M shares 10-Q · filed 2012-11-14 |
| 2012-09-15 | 116.75M shares 10-K/A · filed 2012-10-26 |
| 2012-04-30 | 93.72M shares 10-Q · filed 2012-05-14 |
| 2012-01-31 | 88.03M shares 10-Q · filed 2012-02-14 |
| 2011-10-31 | 80.78M shares 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |